Search

everythinglearnresearchcommunity

for

Search:↓

Women with polycystic ovary syndrome (PCOS) show higher levels of hope, judgement, perspective, and transcendence, and could benefit from positive psychology therapy.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

Insulin resistance is linked to PCOS and can lead to other health issues, but treatments like metformin can help manage symptoms.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

Identifying nonclassic congenital adrenal hyperplasia and carriers of CYP21 mutations is challenging, and genetic counseling is recommended due to their prevalence.

Acne severity is linked to higher levels of certain androgenic hormones, even when those levels are within the normal range.

PCOS is a long-term condition that needs more research for better understanding and treatment.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Chinese women with PCOS have higher androgen levels, which change with age and weight.

STK11 gene variations do not predict how well metformin will work for PCOS, but may affect hair loss and excess hair growth.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

High triglyceride levels are a key factor affecting testosterone levels in women with PCOS.

Eating less starch and dairy helped overweight women with PCOS lose weight and improve symptoms.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

PCOS affects nearly 25% of female medical and dental students, impacting their academic and social lives.

Finasteride reduces hirsutism effectively with fewer side effects but is a second-choice treatment due to safety concerns.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

White hirsute women with PCOS have higher insulin resistance, but similar nitric oxide and fibrinogen levels compared to those with idiopathic hirsutism.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Middle-aged women with PCOS often continue to experience symptoms related to high androgen levels, like unwanted hair growth.